NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $274,000 | +7.0% | 3,133 | 0.0% | 0.02% | +30.8% |
| Q3 2021 | $256,000 | -15.8% | 3,133 | -6.0% | 0.01% | -18.8% |
| Q2 2021 | $304,000 | +6.7% | 3,333 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $285,000 | -28.8% | 3,333 | -21.3% | 0.02% | -40.7% |
| Q4 2020 | $400,000 | +8.7% | 4,233 | 0.0% | 0.03% | -15.6% |
| Q3 2020 | $368,000 | -0.5% | 4,233 | 0.0% | 0.03% | -11.1% |
| Q2 2020 | $370,000 | +6.0% | 4,233 | 0.0% | 0.04% | -26.5% |
| Q1 2020 | $349,000 | -14.9% | 4,233 | -2.3% | 0.05% | +8.9% |
| Q4 2019 | $410,000 | +8.8% | 4,333 | 0.0% | 0.04% | +4.7% |
| Q3 2019 | $377,000 | -22.6% | 4,333 | -18.8% | 0.04% | -24.6% |
| Q2 2019 | $487,000 | -29.9% | 5,333 | -26.3% | 0.06% | -37.4% |
| Q1 2019 | $695,000 | -3.2% | 7,233 | -13.6% | 0.09% | -16.5% |
| Q4 2018 | $718,000 | -0.4% | 8,367 | 0.0% | 0.11% | +25.3% |
| Q3 2018 | $721,000 | – | 8,367 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |